ClinicalTrials.Veeva

Menu

Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users

University of Washington logo

University of Washington

Status

Completed

Conditions

Adherence, Medication
Drug Use
HIV/AIDS

Treatments

Behavioral: Text Messaging
Behavioral: Peer Navigation

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03584282
1R34DA045620-01 (U.S. NIH Grant/Contract)
STUDY00004760

Details and patient eligibility

About

Despite increasing knowledge about and use of PrEP nationally, HIV continues to have disproportionate impact among cisgender men and transgender persons who have sex with men and transgender persons (MSM/TG), with methamphetamine (meth)-users being at particularly high risk. Building on their preliminary work, the investigators will pilot text messaging and peer navigation interventions to support PrEP use among meth-using MSM/TG with potential to be cost-effective, scalable, and easily adaptable.

Full description

Despite increasing knowledge about and use of PrEP nationally, HIV continues to have disproportionate impact among cisgender men and transgender persons who have sex with men and transgender persons (MSM/TG), with methamphetamine (meth)-users being at particularly high risk. Despite apparent high levels of PrEP knowledge and exceptional insurance and medication coverage, few meth-users in Western WA have enrolled in local PrEP programs. The investigators' preliminary work with meth-using MSM/TG has identified both traditional barriers to PrEP and barriers specific for meth users, including competing priorities (e.g., getting high); lack of regularity in daily schedules leading to difficulties complying with appointments and medication adherence; and concomitant wellness and social concerns, notably depression and meth-related stigma. Additional work is needed to develop new strategies to increase PrEP uptake and support persistence and adherence among meth-using MSM/TG. Building on their preliminary work, the investigators will pilot text messaging and peer navigation interventions to support PrEP use among meth-using MSM/TG with potential to be cost-effective, scalable, and easily adaptable. The first, peer navigation, has been studied in ARV treatment and has been proposed for PrEP. The second, text messaging, has been shown to increase ARV and PrEP adherence.

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Meets the clinic's eligibility criteria for PrEP
  • 18 years of age or older
  • HIV-negative
  • Cisgender man or individual on the trans gender variant spectrum who has sex with men
  • Ability to understand, read, and speak English
  • Reports meth use in the past 3 months
  • Has a cell phone able to send and receive text messages

Exclusion criteria

  • PrEP use in the prior month,
  • Discomfort or anxiety with regards to text messaging.
  • Has any circumstances that, based on the study staff's opinion, would preclude provision of informed consent, make participation unsafe, or make it unlikely the participant would be able to participate for 6 months.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

21 participants in 4 patient groups

Standard of Care
No Intervention group
Description:
Participants in this group will receive the standard of care for PrEP follow-up and no additional research interventions.
Text Messaging
Active Comparator group
Description:
Participants in this group will receive the text messaging intervention.
Treatment:
Behavioral: Text Messaging
Peer Navigation
Active Comparator group
Description:
Participants in this group will receive the peer navigator intervention.
Treatment:
Behavioral: Peer Navigation
Text Messaging and Peer Navigation
Active Comparator group
Description:
Participants in this group will receive both the text messaging and peer navigation interventions.
Treatment:
Behavioral: Peer Navigation
Behavioral: Text Messaging

Trial documents
2

Trial contacts and locations

2

Loading...

Central trial contact

Vanessa M McMahan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems